GBLX
OQB GB Sciences Inc$0.0001 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0001, and at the day’s high of $0.0001
- YTD change
- -80.00%
- vs 20-day SMA
- -44.44%
- vs 200-day SMA
- -69.88%
Price ranges
Price & Performance
-0.00 (-66.67%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $1.5600
- GBLX is down 80% since the beginning of the year
- GBLX is down 50% over the past 12 months
- GBLX is down 67% over the past 1 month
GBLX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -50.0%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0000
- Last 5 days
- +0.00%
- vs 8-day SMA
- -20.00%
No alerts for GBLX in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
GB Sciences, Inc. is a biopharmaceutical research and development company, which engages in creating patented, disease-targeted formulations of cannabis, and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. The company was founded on April 4, 2001, and is headquartered in Las Vegas, NV.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
